Browsing All Posts filed under »Pharmaceutical Industry«

Pharma Supply Chains (Part 2): The Optional Supply Chain

October 17, 2011


We’ve discussed why the vast majority of pharma companies will have to build supply chains with new manufacturing, distribution and service-management techniques, and some of the developments that can help them.  But what route should they take? from the PwC White Paper “Pharma 2020: Supplying the future: Which path will you take?” Considering the concern […]

Pharma Supply Chains (Part 1): A problem of focus versus avarice?

October 11, 2011


A report from PricewaterhouseCoopers (PwC) entitled “Supplying The Future: Which Path Will You Take?”, believes that the pharmaceutical supply chain will not be able to cope with new products as it is inefficient and underused. The reason for this conclusion is that PwC believe pharmaceutical companies are too focused on developing new products and regulatory […]

Whether created artificially or reflective of a very real and serious issue, pharmaceutical supply chain problems can have deadly consequences for patients

October 7, 2011


“[Patients] don’t know if they will be able to receive their treatment on time. If they are switched to another regimen, they will always wonder if they got the best treatment and therefore the best chances at survival,” she wrote in an e-mail. from the August 18th, 2011 Globe & Mail article “Health Canada warns […]